NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pediatrics/National Immunisation Schedule
    National Immunisation Schedule
    medium
    smile Pediatrics

    A 6-month-old infant born to an HBsAg-positive mother presents for routine immunisation. The child received HBV vaccine at birth (within 24 hours) and HBIG. What is the most appropriate next step in the immunisation schedule?

    A. Defer all further HBV vaccination until 12 months of age
    B. Administer 2nd dose of HBV vaccine at 6 weeks, 3rd dose at 14 weeks, and check anti-HBs titre at 9 months
    C. Administer only one additional dose of HBV vaccine at 12 months
    D. Administer 2nd dose of HBV vaccine at 6 weeks and check anti-HBs titre at 9 months

    Explanation

    ## Management of Infants Born to HBsAg-Positive Mothers **Key Point:** Infants born to HBsAg-positive mothers require an accelerated HBV vaccination schedule with serological confirmation of response. ### Vaccination Schedule for HBsAg-Positive Mother Infants | Timing | Intervention | |--------|---------------| | Birth (within 24 hrs) | HBV vaccine + HBIG (200 IU) | | 6 weeks | 2nd dose HBV vaccine | | 14 weeks | 3rd dose HBV vaccine | | 9 months | Anti-HBs titre check | **High-Yield:** The accelerated schedule (0, 6 weeks, 14 weeks) differs from the routine schedule (0, 6 weeks, 14 weeks for primary series, then booster at 9-12 months). The critical difference is the timing of the 3rd dose and mandatory serological testing. ### Interpretation of Anti-HBs Titre at 9 Months - **Anti-HBs ≥10 mIU/mL:** Adequate response; routine booster at 12-18 months - **Anti-HBs <10 mIU/mL:** Non-responder; revaccination series required **Clinical Pearl:** HBIG provides immediate passive protection while the vaccine generates active immunity. The combination approach reduces vertical transmission risk from ~90% to <5% if the infant responds adequately. **Warning:** Do NOT delay vaccination or use a standard 3-dose schedule without serological confirmation — this increases the risk of chronic HBV infection in the infant.

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pediatrics Questions